Evidence map›Paper›PMID 30609687›Full record

ArticleMolecules (Basel, Switzerland)2019

Toward of Safer Phenylbutazone Derivatives by Exploration of Toxicity Mechanism.

Rosivaldo S Borges, Ivanete C Palheta, Sirlene S B Ota, Roberto B Morais, Valéria A Barros, Ryan S Ramos, Rai C Silva, Josivan da S Costa, Carlos H T P Silva, Joaquín M Campos and 1 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.7field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Toxicity and Anti-inflammatory Effects ofAnti-inflammatory & anti-allergy agents in medicinal chemistry · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Acute Toxicity and Anti-Inflammatory Activity ofMolecules (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Natural Products-Based Drug Design against SARS-CoV-2 Mpro 3CLpro.International journal of molecular sciences · 2021
    Article
  10. Article
  11. Article
  12. Article
  13. Computational Approaches for Drug Discovery.Molecules (Basel, Switzerland) · 2019
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Rosivaldo S BorgesNúcleo de Estudos e Seleção de Moléculas Bioativas-NESBio, College of Pharmacy, Health Sciences Institute, Federal University of Pará, Belém 66075-110, PA, Brazil. lqfmed@gmail.com.
Ivanete C PalhetaNúcleo de Estudos e Seleção de Moléculas Bioativas-NESBio, College of Pharmacy, Health Sciences Institute, Federal University of Pará, Belém 66075-110, PA, Brazil. ivapalheta@gmail.com.
Sirlene S B OtaNúcleo de Estudos e Seleção de Moléculas Bioativas-NESBio, College of Pharmacy, Health Sciences Institute, Federal University of Pará, Belém 66075-110, PA, Brazil. sayuriota@gmail.com.
Roberto B MoraisNúcleo de Estudos e Seleção de Moléculas Bioativas-NESBio, College of Pharmacy, Health Sciences Institute, Federal University of Pará, Belém 66075-110, PA, Brazil. robertomorais16@hotmail.com.br.
Valéria A BarrosNúcleo de Estudos e Seleção de Moléculas Bioativas-NESBio, College of Pharmacy, Health Sciences Institute, Federal University of Pará, Belém 66075-110, PA, Brazil. valbarros43@yahoo.com.br.
Ryan S RamosPrograma de Pós-Graduação em Biodiversidade e Biotecnologia-Rede BIONORTE, Federal University of Amapá, Macapá 68902-280, AP, Brazil. ryanquimico@hotmail.com.ORCID 0000-0003-1802-1320
Rai C SilvaPrograma de Pós-Graduação em Química Medicinal e Modelagem Molecular, Health Science Institute, Federal University of Pará, Belém 66075-110, PA, Brazil. camposchemistry@gmail.com.
Josivan da S CostaLaboratorio de Modelagem e Química Computacional-LMQC, Federal University of Amapá, Department of Biological Sciences. Rod. Juscelino Kubitschek, Km 02, Macapá 68902-280, AP, Brazil. josivan.chemistry@gmail.com.ORCID 0000-0001-5069-5283
Carlos H T P SilvaLaboratório Computacional de Química Farmacêutica, Faculdade de Ciências Farmacêuticas de Ribeirão Preto, University of Sao Paulo, São Paulo 14040-903, SP, Brazil. tomich@fcfrp.usp.br.
Joaquín M CamposDepartment of Pharmaceutical Organic Chemistry, University of Granada, 18071 Granada, Spain. jmcampos@ugr.es.ORCID 0000-0002-9035-8123
Cleydson B R SantosPrograma de Pós-Graduação em Química Medicinal e Modelagem Molecular, Health Science Institute, Federal University of Pará, Belém 66075-110, PA, Brazil. breno@unifap.br.ORCID 0000-0002-0271-335X
Universidade Federal do Pará · BRUniversidade Federal do Amapá · BRUniversidad de Granada · ESUniversidade de São Paulo · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A drug design for safer phenylbutazone was been explored by reactivity and docking studies involving single electron transfer mechanism, as well as toxicological predictions. Several approaches about its structural properties were performed through quantum chemistry calculations at the B3LYP level of theory, together with the 6-31+G(d,p) basis sets. Molecular orbital and ionization potential were associated to electron donation capacity. The spin densities contribution showed a preferential hydroxylation at the

Indexed as

Drug DiscoveryHumansHydrophobic and Hydrophilic InteractionsModels, MolecularMolecular ConformationMolecular StructurePhenylbutazoneStructure-Activity RelationshipPhenylbutazoneDFTelectron transfermetabolismphenylbutazonetoxicity

Identifiers

PMID30609687
PMCPMC6337259
OpenAlexW2908444098

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.